- Home
- PMT vs IRON Comparison
PMT vs IRON Comparison
Compare PMT & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMT
- IRON
- Stock Information
- Founded
- PMT 2009
- IRON 2017
- Country
- PMT United States
- IRON United States
- Employees
- PMT N/A
- IRON N/A
- Industry
- PMT Real Estate Investment Trusts
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- PMT Real Estate
- IRON Health Care
- Exchange
- PMT Nasdaq
- IRON Nasdaq
- Market Cap
- PMT 1.2B
- IRON 1.4B
- IPO Year
- PMT 2009
- IRON N/A
- Fundamental
- Price
- PMT $13.06
- IRON $65.01
- Analyst Decision
- PMT Buy
- IRON Strong Buy
- Analyst Count
- PMT 6
- IRON 10
- Target Price
- PMT $15.17
- IRON $73.70
- AVG Volume (30 Days)
- PMT 728.1K
- IRON 243.3K
- Earning Date
- PMT 01-30-2025
- IRON 11-12-2024
- Dividend Yield
- PMT 12.25%
- IRON N/A
- EPS Growth
- PMT 16.86
- IRON N/A
- EPS
- PMT 1.41
- IRON N/A
- Revenue
- PMT $807,048,000.00
- IRON N/A
- Revenue This Year
- PMT N/A
- IRON N/A
- Revenue Next Year
- PMT $24.53
- IRON N/A
- P/E Ratio
- PMT $9.25
- IRON N/A
- Revenue Growth
- PMT 57.27
- IRON N/A
- 52 Week Low
- PMT $12.80
- IRON $25.60
- 52 Week High
- PMT $15.89
- IRON $77.60
- Technical
- Relative Strength Index (RSI)
- PMT 39.71
- IRON 55.60
- Support Level
- PMT $12.80
- IRON $61.07
- Resistance Level
- PMT $13.83
- IRON $67.87
- Average True Range (ATR)
- PMT 0.23
- IRON 3.50
- MACD
- PMT -0.05
- IRON -0.47
- Stochastic Oscillator
- PMT 25.24
- IRON 54.56
About PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through four segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies, and corporate activities. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.